Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: a multicentre, retrospective study.
Robertson JD, Higgins P, Price J, Dunkley S, Barrese G, Curtin J. Robertson JD, et al. Thromb Res. 2014 Nov;134(5):1046-51. doi: 10.1016/j.thromres.2014.09.010. Epub 2014 Sep 21. Thromb Res. 2014. PMID: 25267706 Free article.
Australian and New Zealand consensus guideline for paediatric newly diagnosed immune thrombocytopaenia endorsed by Australian New Zealand Children's Haematology and Oncology Group.
Verissimo V, Carter T, Wright H, Robertson J, Osborn M, Bradbeer P, Sabesan V, Saxon B, Barbaro P, Crighton G, Chamberlain J, Zheng S, Freeman K. Verissimo V, et al. J Paediatr Child Health. 2023 May;59(5):711-717. doi: 10.1111/jpc.16395. Epub 2023 Apr 18. J Paediatr Child Health. 2023. PMID: 37071068
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.
Monagle P, Lensing AWA, Thelen K, Martinelli I, Male C, Santamaría A, Samochatova E, Kumar R, Holzhauer S, Saracco P, Simioni P, Robertson J, Grangl G, Halton J, Connor P, Young G, Molinari AC, Nowak-Göttl U, Kenet G, Kapsa S, Willmann S, Pap AF, Becka M, Twomey T, Beyer-Westendorf J, Prins MH, Kubitza D; EINSTEIN-Jr Phase 2 Investigators. Monagle P, et al. Lancet Haematol. 2019 Oct;6(10):e500-e509. doi: 10.1016/S2352-3026(19)30161-9. Epub 2019 Aug 13. Lancet Haematol. 2019. PMID: 31420317 Clinical Trial.
310 results